Bone marrow-derived mononuclear cells for treatment of myocardial infarction
The aim of this study is to assess the efficacy of intra-coronary injection of autologous bone marrow-derived mononuclear cells (BM-MNCs) in the teatment of extensive myocardial infarction.
Read More
Product Information for
Bone marrow-derived mononuclear cells for treatment of myocardial infarction